IMRT 2018

Biological Challenges to the 5 Rs for SABR

Crude local control rates (2 years) redrawn from a pooled analysis reported by Mehta et al (3D-CRT and SABR regimens)

Dose Escalation, not “new biology,” can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer

Brown et al, IJROBP 2014